A retrospective multi-cohort study showed that the m6A eraser ALKBH5 was an independent prognostic factor for pancreatic cancer, and its expression was positively associated with the OS of pancreatic cancer patients [31]. Here, ALKBH5 is linked to pancreatic neoplasm.